AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Acalabrutinib in South Africa
3 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ACALABRUTINIB CIPLA | 57/26/0033 | Cipla Medpro (Pty) Ltd | active | 4 Jul 2028 |
| GENCALQ | 57/26/0034.033 | Cipla Medpro (Pty) Ltd | active | 4 Jul 2028 |
| CALQUENCE | 55/26/0390 | AstraZeneca Pharmaceuticals (Pty) Ltd | active | 29 Mar 2027 |
Acalabrutinib — SAHPRA Registration Details
SAHPRA (South Africa) has 3 registered products containing Acalabrutinib, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Acalabrutinib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.